Giannakopoulos X, Grammeniatis E, Chambilomatis P, Baltogiannis D
Department of Urology, Ioannina University School of Medicine, University Hospital, Greece.
Int Urol Nephrol. 1997;29(1):33-8. doi: 10.1007/BF02551414.
Numerous modalities of treatment have been used in the past to control massive bladder haematuria, with varying degrees of success. Formalin has been used in urology only for the treatment of intractable haematuria of inoperable bladder carcinomas, usually as the last resort when all other nonsurgical attempts have failed and before more aggressive surgical measures are considered. Eight patients with bladder tumours classified T2 (2 cases), T3 (2 cases) or T4 (4 cases) and 2 patients with radiation cystitis were assessed as being beyond the scope of even palliative surgery, severe haemorrhage being present in all cases. The treatment was instituted in all cases by intravesical instillation of a 10 per cent formalin solution under general anaesthesia. Four patients received 4 and 6 instillations, respectively, the former over 4 weeks and the latter over 10 months. The bladder was filled completely and an indwelling-catheter introduced, the formalin solution being left in the bladder for 5 to 30 min (mean: 12 min). Haematuria was absent after 1 to 25 days (mean: 11 days) in 9 cases. The 10th patient died before arrest of haemorrhage. Survival after instillation was 65 days to 27 months (mean: 11.5 months). The outcome was fatal within 4 months or less in 3 cases and 4 patients died of renal failure within 3 months, one within 65 days after instillation. In 4 cases, treatment with formalin reduced bladder capacity to less than 100 ml. Other complications included retroperitoneal fibrosis (1 case), urinary incontinence (3 cases) and severe frequency and nocturia (3 cases). This procedure should therefore be reserved for terminal cases unable to support more aggressive therapy.
过去曾使用多种治疗方法来控制严重的膀胱血尿,成功率各不相同。福尔马林在泌尿外科仅用于治疗无法手术的膀胱癌引起的顽固性血尿,通常是在所有其他非手术尝试均失败且在考虑采取更积极的手术措施之前作为最后的手段。8例膀胱肿瘤患者,肿瘤分期为T2(2例)、T3(2例)或T4(4例),2例放射性膀胱炎患者被评估为甚至超出了姑息性手术的范围,所有病例均有严重出血。所有病例均在全身麻醉下经膀胱内灌注10%的福尔马林溶液进行治疗。4例患者分别接受了4次和6次灌注,前者持续4周,后者持续10个月。膀胱完全充盈后插入留置导尿管,福尔马林溶液在膀胱内保留5至30分钟(平均12分钟)。9例患者在1至25天(平均11天)后血尿消失。第10例患者在出血停止前死亡。灌注后的生存期为65天至27个月(平均11.5个月)。3例患者在4个月或更短时间内死亡,4例患者在3个月内死于肾衰竭,1例在灌注后65天内死亡。4例患者经福尔马林治疗后膀胱容量减少至100毫升以下。其他并发症包括腹膜后纤维化(1例)、尿失禁(3例)以及严重的尿频和夜尿(3例)。因此,该方法应仅用于无法耐受更积极治疗的终末期病例。